183 related articles for article (PubMed ID: 16776195)
1. [Thyroid malignant lymphoma].
Noh JY; Shimizu T; Ito K
Nihon Rinsho; 2006 May; Suppl 1():482-4. PubMed ID: 16776195
[No Abstract] [Full Text] [Related]
2. [Malignant lymphoma of the thyroid].
Ohye H; Fukata S; Hirokawa M
Nihon Rinsho; 2007 Nov; 65(11):2092-8. PubMed ID: 18018576
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of malignant lymphoma with extranodal lesions--indications and timing for local therapies].
Kinoshita T; Kagami Y
Rinsho Ketsueki; 1999 Mar; 40(3):192-5. PubMed ID: 10222624
[No Abstract] [Full Text] [Related]
4. [Diagnosis and therapy of malignant thyroid lymphoma].
Kuma K; Matsuzuka F
Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1190-5. PubMed ID: 9379098
[No Abstract] [Full Text] [Related]
5. [Clinical features of extranodal malignant lymphoma--staging classification and treatment strategies].
Takagi T
Rinsho Ketsueki; 1999 Mar; 40(3):188-91. PubMed ID: 10222623
[No Abstract] [Full Text] [Related]
6. A Bayesian approach to a patient with a residual mass after treatment for non-Hodgkin's lymphoma of the thyroid.
Bibb J; Hromas R; Rabinowitz I
J Clin Oncol; 2005 Dec; 23(34):8911-3. PubMed ID: 16314654
[No Abstract] [Full Text] [Related]
7. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases.
Matsuzuka F; Miyauchi A; Katayama S; Narabayashi I; Ikeda H; Kuma K; Sugawara M
Thyroid; 1993; 3(2):93-9. PubMed ID: 8369658
[TBL] [Abstract][Full Text] [Related]
8. Images for surgeons. Thyroid lymphoma arising from Hashimoto's thyroiditis.
Nasiri S; Mahmoodzadeh H; Sharifi M
ANZ J Surg; 2008 Dec; 78(12):1134. PubMed ID: 19087060
[No Abstract] [Full Text] [Related]
9. The rapidly expanding role of rituximab in the treatment of aggressive B-cell lymphoma.
Cooper D
Cancer J; 2002; 8(5):364-6. PubMed ID: 12416891
[No Abstract] [Full Text] [Related]
10. Rituximab in relapsed aggressive lymphoma: play it again, Sam?
Dreyling M; Schmidt C
Leuk Lymphoma; 2010 Mar; 51(3):355-6. PubMed ID: 20148756
[No Abstract] [Full Text] [Related]
11. Rituximab in the treatment of primary bilateral adrenal lymphoma with adrenal crisis.
Lim KH; Chiou TY; Lin CJ; Hsieh RK
Med Oncol; 2008; 25(1):107-9. PubMed ID: 18188724
[TBL] [Abstract][Full Text] [Related]
12. [Advances in management of follicular lymphoma].
Zinzani PL
Rinsho Ketsueki; 2014 Oct; 55(10):1937-40. PubMed ID: 25297758
[No Abstract] [Full Text] [Related]
13. Rituximab plus dose-reduced cyclophosphamide, mitoxantrone, vincristine, and prednisolone are effective in elderly patients with diffuse large B-cell lymphoma of the thyroid.
Jonak C; Troch M; Müllauer L; Niederle B; Hoffmann M; Raderer M
Thyroid; 2010 Apr; 20(4):425-7. PubMed ID: 20210673
[TBL] [Abstract][Full Text] [Related]
14. [Immunotherapy with monoclonal antibody of malignant lymphoma].
Ogura M
Nihon Rinsho; 2007 Jan; 65 Suppl 1():545-60. PubMed ID: 17474462
[No Abstract] [Full Text] [Related]
15. Primary diffuse large B-cell lymphoma of the testis relapsing in the right atrium.
Yamamoto E; Tomita N; Ishigatsubo Y
Br J Haematol; 2015 Feb; 168(4):469. PubMed ID: 25403768
[No Abstract] [Full Text] [Related]
16. Complete and durable remission of refractory mantle cell lymphoma with repeated rituximab monotherapy.
Ishiyama K; Takami A; Okumura H; Ozaki J; Shimadoi S; Yamanaka S; Nakao S
Int J Hematol; 2005 May; 81(4):319-22. PubMed ID: 15914363
[TBL] [Abstract][Full Text] [Related]
17. Rituximab with chemotherapy improves survival of non-germinal center type untreated diffuse large B-cell lymphoma.
Saito B; Shiozawa E; Usui T; Nakashima H; Maeda T; Hattori N; Shimozuma J; Adachi D; Yamochi-Onizuka T; Takimoto M; Nakamaki T; Ota H; Tomoyasu S
Leukemia; 2007 Dec; 21(12):2563-6. PubMed ID: 17597802
[No Abstract] [Full Text] [Related]
18. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + 1-131 tositumomab for newly diagnosed follicular non-Hodgkin lymphoma.
Clin Adv Hematol Oncol; 2006 Jul; 4(7):536-8. PubMed ID: 17147240
[No Abstract] [Full Text] [Related]
19. R-CHOP followed by consolidative autologous stem cell transplant and low dose rituxan maintenance therapy for advanced mantle cell lymphoma.
Lim SH; Esler WV; Periman PO; Beggs D; Zhang Y; Townsend M
Br J Haematol; 2008 Jul; 142(3):482-4. PubMed ID: 18510683
[No Abstract] [Full Text] [Related]
20. False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma.
Inoue Y; Tamaki H; Yamagami T; Iwasaki H; Nakatsuka S; Soma T
Eur J Haematol; 2007 Jul; 79(1):88-90. PubMed ID: 17532762
[No Abstract] [Full Text] [Related]
[Next] [New Search]
